Antimicrobial resistance — a ‘rising tide’ of national (and international) risk

J. Cole^*
*Royal United Services Institute for Defence and Security Studies, UK
Journal of Hospital Infection (2016) 92, 3-4
No Abstract.
サマリー原文（英語）はこちら
監訳者コメント：
グローバルな視点に立って耐性菌の課題を突きつけている提言である。テロも怖いが耐性菌も深刻な問題であると指摘している。生命予後ならびに経済的損失についても推計値をもとに解説している。

Assessing the stability and sporicidal efficacy of oxidizing disinfectants

L. Brown*, A. Marshall, L. Conway, J. Otter, P. Norville, J. Clarke
*Fellows Research Centre, Gama Healthcare Ltd, UK

Journal of Hospital Infection (2024) 149, 22-25

Air dispersal of multidrug-resistant Acinetobacter baumannii: implications for nosocomial transmission during the COVID-19 pandemic

S.-C. Wong*, G.K.-M. Lam, J.H.-K. Chen, X. Li, F.T.-F. Ip, L.L.-H. Yuen, V.W.-M. Chan, C.H.-Y. AuYeung, S.Y.-C. So, P.-L. Ho, K.-Y. Yuen, V.C.-C. Cheng
*Hong Kong West Cluster, China

Journal of Hospital Infection (2021) 116, 78-86

Critical points and potential pitfalls of outbreak of IMP-1-producing carbapenem-resistant Pseudomonas aeruginosa among kidney transplant recipients: a case-control study

M.P. Freire*, C.H. Camargo, A.Y. Yamada, F.O. Nagamori, J.O. Reusing Junior, F. Spadão, A.P. Cury, F. Rossi, W.C. Nahas, E. David-Neto, L.C. Pierrotti
*University of São Paulo School of Medicine Hospital das Clínicas, Brazil

Journal of Hospital Infection (2021) 115, 83-92

Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach

Epidemiology of infection and current guidelines for infection prevention in cystic fibrosis patients